MENU
+Compare
HKMPF
Stock ticker: OTC
AS OF
May 20 closing price
Price
$27.73
Change
+$0.80 (+2.97%)
Capitalization
5.93B

HKMPF Hikma Pharmaceuticals plc. Forecast, Technical & Fundamental Analysis

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products... Show more

HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HKMPF with price predictions
Jul 03, 2025

Aroon Indicator for HKMPF shows an upward move is likely

HKMPF's Aroon Indicator triggered a bullish signal on June 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 129 similar instances where the Aroon Indicator showed a similar pattern. In of the 129 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HKMPF turned negative on June 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.737) is normal, around the industry mean (62.813). P/E Ratio (31.646) is within average values for comparable stocks, (89.433). HKMPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.021) settles around the average of (0.124) among similar stocks. P/S Ratio (2.365) is also within normal values, averaging (19.290).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HKMPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HKMPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

HKMPF paid dividends on May 01, 2025

Hikma Pharmaceuticals plc. HKMPF Stock Dividends
А dividend of $0.48 per share was paid with a record date of May 01, 2025, and an ex-dividend date of March 20, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1 New Burlington Place
Phone
+44 2073992760
Employees
8800
Web
https://www.hikma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KEUA24.150.23
+0.94%
KraneShares European Carb Allw Stgy ETF
SEPW30.290.09
+0.28%
AllianzIM U.S. Large Cp Buffer20 Sep ETF
EOD5.42N/A
N/A
Allspring Global Dividend Opportunity Fund
LIAO209.51N/A
N/A
LifeX 2056 Infl-Prt Longevity Inc ETF
YINN39.39-1.35
-3.31%
Direxion Daily FTSE China Bull 3X ETF

HKMPF and Stocks

Correlation & Price change

A.I.dvisor tells us that HKMPF and AMPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPF and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
AMPH - HKMPF
24%
Poorly correlated
-1.61%
CAIHF - HKMPF
24%
Poorly correlated
N/A
HLTRF - HKMPF
11%
Poorly correlated
N/A
GRUSF - HKMPF
9%
Poorly correlated
-1.11%
ESALF - HKMPF
7%
Poorly correlated
N/A
More